Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant <i>A.</i><i>baumannii</i> in Cancer Patient

Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant <i>A.</i><i>baumannii</i> in Cancer Patient

Carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is one of the most commonly reported nosocomial infections in cancer patients and could be fatal because of suboptimal immune defenses in these patients. We aimed to compare clinical response, microbiological response, nephrotoxi...

Full description

Bibliographic Details
Main Authors: Wasan Katip, Suriyon Uitrakul, Peninnah Oberdorfer
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Antibiotics
Subjects:
cancer patients
duration of treatment
colistin
propensity score analysis
multidrug-resistant <i>Acinetobacter baumannii</i>
Online Access:https://www.mdpi.com/2079-6382/10/5/484

Similar Items

Similar Items